Filtered By:
Therapy: Hormonal Therapy
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 73 results found since Jan 2013.
Dense breasts on a mammogram? What to know and do
You’re staring at a letter from your mammography facility. Your breast exam was normal, great. But then you see a note on the bottom: you have high breast density, which could put you at higher risk for breast cancer in the future. Now what?
“The finding of dense breasts on a mammogram can be stressful and confusing for patients,” says Dr. Toni Golen, acting editor in chief of Harvard Women’s Health Watch. It’s information that may concern them, but they don’t know what to do about it.
What is breast density?
Breasts are composed of:
lobules, which produce milk
ducts, tubes that carry milk ...
Source: Harvard Health Blog - October 1, 2019 Category: Consumer Health News Authors: Kelly Bilodeau Tags: Breast Cancer Health Tests and procedures Women's Health Source Type: blogs
Common hormonal treatments linked to abnormal heart rhythms and sudden death in men being treated for prostate cancer
Treatments for advanced prostate cancer that suppress testosterone, a hormone (also called an androgen) that drives the malignant cells to grow and spread, are collectively referred to as androgen deprivation therapies, or ADT. These therapies can significantly extend lifespans in men who have the disease, but they also have a range of challenging side effects.
In 2004, Dr. Marc Garnick, Gorman Brothers Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center, and editor in chief of HarvardProstateKnowledge.org, reported that in some men, an ADT drug called aberelix lengthens the time it tak...
Source: Harvard Health Blog - September 20, 2019 Category: Consumer Health News Authors: Charlie Schmidt Tags: Health Living With Prostate Cancer Men's Health Prostate Health Prostate Knowledge Treatments HPK Source Type: blogs
Fight Aging! Newsletter, April 15th 2019
In this study, we found that senescent chondrocytes isolated from OA patients secrete more EVs compared with nonsenescent chondrocytes. These EVs inhibit cartilage ECM deposition by healthy chondrocytes and can induce a senescent state in nearby cells. We profiled the miR and protein content of EVs isolated from the synovial fluid of OA joints from mice with SnCs. After treatment with a molecule to remove SnCs, termed a senolytic, the composition of EV-associated miR and protein was markedly altered. The senolytic reduced OA development and enhanced chondrogenesis, and these were attributable to several specific differenti...
Source: Fight Aging! - April 14, 2019 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Weekly Overseas Health IT Links – 9th February, 2019.
Here are a few I came across last week.Note: Each link is followed by a title and few paragraphs. For the full article click on the link above title of the article. Note also that full access to some links may require site registration or subscription payment.-----https://www.healthdatamanagement.com/news/messages-in-patient-portal-help-predict-medication-discontinuationPatient portal helps predict medication discontinuation By Greg SlabodkinPublished February 01 2019, 7:19am ESTResearchers say electronic communication between patients and providers via an online portal can indicate their potential for stopping therapy.A t...
Source: Australian Health Information Technology - February 9, 2019 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
Preserving fertility during cancer treatments
Cancer treatment — and cancer itself — can threaten fertility. This is a tremendously important survivorship issue for many people. As an oncologist, I’m often asked questions about preserving fertility during cancer treatment. If this issue affects you, here is an overview of key options.
When should you talk to your cancer team about fertility?
Future children may not be foremost on your mind when you are diagnosed with cancer. Soon afterward, though, it’s worth talking to your doctor about fertility issues, if this is important to you now or might one day become important.
Your doctor can explain:
the risk that...
Source: Harvard Health Blog - February 4, 2019 Category: Consumer Health News Authors: Ann Partridge, MD, MPH Tags: Cancer Fertility Infertility Source Type: blogs
Alternative therapies for cancer
This study was not designed to directly compare non-conventional therapies with conventional ones, and the results do not mean that all unproven remedies are useless. In fact, an unproven treatment may become conventional if rigorous research proves its worth. There are many types of alternative treatments (including herbs, vitamins, homeopathy, yoga, and acupuncture) that might have different effects and have not yet been well studied. Importantly, this study did not examine the interaction of conventional and alternative treatments (which in some cases may cause problems).
In addition, this study did not actually find th...
Source: Harvard Health Blog - February 1, 2019 Category: Consumer Health News Authors: Robert H. Shmerling, MD Tags: Cancer Complementary and alternative medicine Health Source Type: blogs
Hormonal therapy for aggressive prostate cancer: How long is enough?
This study reaffirms what many clinicians have put into practice: longer duration hormonal therapy in appropriately selected patient populations provides a greater benefit,” said Dr. Marc Garnick, the Gorman Brothers Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center, and editor in chief of HarvardProstateKnowledge.org. “Prior studies using three years of hormonal therapy have also shown this, but it is important to recognize that some men may have significantly delayed return of the body’s testosterone upon completion of the therapy — a fact that needs to be discussed when con...
Source: Harvard Health Blog - January 28, 2019 Category: Consumer Health News Authors: Charlie Schmidt Tags: Health Living With Prostate Cancer Prostate Knowledge Treatments HPK Source Type: blogs
“News (Hot) Flash: Sex, Drugs and Menopause” Recap – 2010 Breakfast Series
Our panel this morning discussed the issues surrounding how the WHI results were interpreted and communicated to women and their health care providers. We recognize that hormones are not appropriate for all women, and look forward to hosting a future panel that highlights alternatives.
The speakers have a variety of backgrounds and experiences (and genders), and we aim to promote diversity of voices.
This was not normal breakfast conversation.
Today was a jolting – and disruptive – talk about what happens to women’s bodies when they age. (Who knew that if you’re menopausal and you don’t take your hormones, your v...
Source: Disruptive Women in Health Care - September 25, 2018 Category: Consumer Health News Authors: dw at disruptivewomen.net Tags: Uncategorized Source Type: blogs
New blood test may someday help guide the best treatment for aggressive prostate cancer
Tumors that spread, or metastasize, in the body shed cells into blood that doctors can scrutinize for insights into what a patient’s cancer might do. Analyzing these so-called circulating tumor cells (CTCs) isn’t part of routine care yet, in part because they’re so hard to pick out of the millions of normal cells in a blood sample. Still, scientists are making progress in this area. And in June, a research team reported that treatment decisions made on the basis of CTC testing had increased lifespans in men with an aggressive type of metastatic prostate cancer.
Doctors usually treat metastatic prostate cancer with d...
Source: Harvard Health Blog - August 1, 2018 Category: Consumer Health News Authors: Charlie Schmidt Tags: Cancer Health Men's Health Prostate Health Source Type: blogs
Rethinking the screening mammogram
This study analyzed data from women over 40 and compared the size of breast cancers at the time of diagnosis detected in the 1970s (before mammography became common) with the size of tumors detected between 2000 and 2002, when screening mammography was routine. Treatments and rates of death due to breast cancer 10 years after the diagnosis were also analyzed. The study found that:
As more women underwent routine screening mammograms, more small breast cancers were detected. Many of these tumors were restricted to the ducts within the breast (called ductal carcinoma in situ), and even without treatment would never threaten...
Source: Harvard Health Blog - June 28, 2018 Category: Consumer Health News Authors: Robert H. Shmerling, MD Tags: Health Source Type: blogs
A mix of treatments may extend life for men with aggressive prostate cancer
For men diagnosed with aggressive cancer that’s confined to the prostate and nearby tissues, the overarching goal of treatment is to keep the disease from spreading (or metastasizing) in the body. Doctors can treat these men with localized therapies, such as surgery and different types of radiation that target the prostate directly. And they can also give systemic treatments that kill off rogue cancer cells in the bloodstream. Hormonal therapy, for instance, is a systemic treatment that kills prostate cancer cells by depriving them of testosterone, which fuels their growth.
Now a new study shows that a mix of different t...
Source: Harvard Health Blog - March 31, 2018 Category: Consumer Health News Authors: Charlie Schmidt Tags: Cancer Men's Health Prostate Health Source Type: blogs
FDA approves new drug for men at high risk of prostate cancer spread
A newly approved drug called apalutamide is giving hope to thousands of men confronting a tenacious problem after being treated for prostate cancer. Prostate-specific antigen (PSA) levels should plummet to zero after surgery, and to near zero after radiation therapy, but in some men, they continue rising even when there’s no other evidence of cancer in the body. Doctors typically respond to spiking PSA with drugs that block the production of testosterone, which is the male sex hormone that fuels prostate cancer. However, this type of medically induced castration, called hormonal therapy, doesn’t always reduce PSA. More...
Source: Harvard Health Blog - March 15, 2018 Category: Consumer Health News Authors: Charlie Schmidt Tags: Cancer Health Men's Health Prostate Health Source Type: blogs
Obstruction of medical justice: How health care fails patients with cancer
Isn’t getting cancer bad enough?
That’s the frustrated thought that goes through my mind when I see patients with cancer suffering — not from their cancer, but from the failure of the health care system.
Take Nancy,* a 60-year-old woman with hormone-positive breast cancer. When she came to the emergency room with a fungating breast mass, we knew immediately she had ignored it for a long time; she said she hadn’t been able to see a doctor because she didn’t have insurance. But after confirming the diagnosis of incurable metastatic breast cancer, she was discharged home to continue with hormone therapy. One yea...
Source: Kevin, M.D. - Medical Weblog - January 22, 2018 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/miriam-a-knoll" rel="tag" > Miriam A. Knoll, MD < /a > Tags: Policy Oncology/Hematology Public Health & Source Type: blogs
Why do some breast cancer patients decline chemotherapy and radiation?
Adjuvant therapy after surgery, such as chemotherapy, hormonal therapy, and radiation therapy, has contributed to a 39% decrease in breast cancer mortality since 1989. Unfortunately, a significant number of women decline evidence-based adjuvant therapy. A recent study suggests that distrust of the medical system plays a significant role in such refusal.
The post Why do some breast cancer patients decline chemotherapy and radiation? appeared first on RESPECTFUL INSOLENCE.
Source: Respectful Insolence - November 20, 2017 Category: Surgery Authors: Orac Tags: Cancer Medicine Skepticism/critical thinking Surgery adjuvant breast cancer chemotherapy radiation therapy Source Type: blogs
Life After Breast Cancer Does Suck
Here ' s the truth. "The Secret Suckiness to Life After Breast Cancer" . Go read it. Judith Basya writes the truth. There is no new normal. Cancer lurks for ever. And life on some levels, really does suck after breast cancer. And they never told us about it and we don ' t get to talk about it.Judith raises some good points including this one which resonates with me most:" And why is my situation only to be discussed in therapy, while other people ’s job woes are acceptable dinner-table fodder? "Yes, really? Why don ' t we talk about post breast cancer suckiness in therapy and not at the dinner table? Our family members a...
Source: Caroline's Breast Cancer Blog - November 2, 2017 Category: Cancer & Oncology Tags: breast cancer bonds coping friends questions secrets Source Type: blogs
